Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain

British Journal of Pharmacology

Volumn 143, Issue 7, 2004, Pages 833-844

  Vale, Mariana L ^a   Benevides, Verônica M ^a   Sachs, Daniela ^b   Brito, Gerly A C ^a   Da Rocha, Francisco A C ^a   Poole, Stephen ^c   Ferreira, Sérgio H ^b   Cunha, Fernando Q ^b   Ribeiro, Ronaldo A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Cytokines; Hyperalgesia; Inflammation; Interleukin; Pain; Pentoxifylline; Tumor necrosis factor; Zymosan

Indexed keywords

ACETIC ACID; CYTOKINE; ILOPROST; INTERLEUKIN 1BETA; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANALGESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ACETIC ACID; ANIMALS; ARTHRITIS, EXPERIMENTAL; CARRAGEENAN; HEAT; HYPERALGESIA; ILOPROST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; JOINTS; MALE; MICE; PAIN; PAIN MEASUREMENT; PENTOXIFYLLINE; PERITONEAL CAVITY; PHOSPHODIESTERASE INHIBITORS; PHYSICAL STIMULATION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 10844263351     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705999     Document Type: Article

References (85)

1. AARESTRUP, F.M., GONCALVES-DA-COSTA, S.C. & SARNO, E.N. (1995). The effect of thalidomide on BCG-induced granulomas in mice. Braz. J. Med. Biol. Res., 28, 1069-1076.
2. ACCETTO, B. (1982). Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin. Am. Heart J., 103, 864-869.
3. ALEY, K.O. & LEVINE, J.D. (1999). Role of protein kinase A in the maintenance of inflammatory pain. J. Neurosci., 19, 2181-2186.
4. ALEY, K.O., MESSING, R.O., MOCHLY-ROSEN, D. & LEVINE, J.D. (2000). Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J. Neurosci., 20, 4680-4685.
5. BAYER, E.A. & WILCHEK, W. (1980). The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem. Anal., 26, 1-45.
6. BERTINI, R., MENGOZZI, M., BIANCHI, M., SIPE, J.D. & GHEZZI, P. (1991). Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo. Int. J. Immunopharmacol., 13, 1085-1090.
7. BEUTLER, B. & CERAMI, A. (1988). Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr. Rev., 9, 57-66.
8. BORASCHI, D., CIFONE, M.G., FALK, W., FLAD, H.D., TAGLIABUE, A. & MARTIN, M.U. (1998). Cytokines in inflammation. Eur. Cytokine Netw., 9, 205-212.
9. BRITO, G.A., SARAIVA, S.N., FALCAO, J.L., VALE, M.L., LIMA, A.A., CUNHA, F.Q. & RIBEIRO, R.A. (2001). Dual effect of cAMP on the writhing response in mice. Eur. J. Pharmacol., 416, 223-230.
10. COLLIER, H.O.J., DINNEEN, L.C., CHISTINE, A., JOHNSON, A. & SCHNEIDER, C. (1968). The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother., 32, 295-310.
11. CUNHA, F.Q., BOUKILI, M.A., MOTTA, J.I.B., VARGAFTIG, B.B. & FERREIRA, S.H. (1993). Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur. J. Pharmacol., 238, 47-52.
12. CUNHA, F.Q., LORENZETTI, B.B., POOLE, S. & FERREIRA, S.H. (1991). Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol., 104, 765-767.
13. CUNHA, F.Q., POOLE, S., LOREZETTI, B.B. & FERREIRA, S.H. (1992). The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol., 107, 660-664.
14. CUNHA, F.Q., TEIXEIRA, M.M. & FERREIRA, S.H. (1999). Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP - on inflammatory hyperalgesia. Br. J. Pharmacol., 127, 671-678.
15. DAVIS, A.J. & PERKINS, M.N. (1994). The involvement of bradykinin BI and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol., 113, 63-68.
16. DEZUBE, B.J., SHERMAN, M.L., FRIDOVICH-KEIL, J.L., ALLEN-RYAN, J. & PARDEE, A.B. (1993). Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol. Immunother., 36, 57-60.
17. D'HELLENCOURT, C.L., DIAW, L., CORNILLET, P. & GUENOUNOU, M. (1996). Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int. J. Immunopharmacol., 18, 739-748.
18. DINARELLO, C.A. (1996). Thermoregulation and the pathogenesis of fever. Infect. Dis. Clin. North. Am., 10, 433-449.
19. DINARELLO, C.A. (2000). Pro-inflammatory cytokines. Chest, 118, 503-508.
20. DOHERTY, G.M., JENSEN, J.C., ALEXANDER, H.R., BURESH, C.M. & NORTON, J.A. (1991). Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery, 110, 192-198.
21. DORAZIL-DUDZIK, M., MIKA, J., SCHAFER, M.K., LI, Y., OBARA, I., WORDLICZEK, J. & PRZEWLOCKA, B. (2004). The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth. Analg., 98, 1566-1573.
22. EDDY, N.B. & LEIMBACH, D. (1953). Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. Exp. Ther., 107, 385-393.
23. FACCIOLI, L.H., SOUZA, G.E., CUNHA, F.Q., POOLE, S. & FERREIRA, S.H. (1990). Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration 'in vivo' by indirect mechanisms. Agents Actions. 30, 344-349.
24. FELDMANN, M., BRENNAN, F.M., CHANTRY, D., HAWORTH, C., TURNER, M., ABNEY, E., BUCHAN, G., BARRETT, K., BARKLEY, D. & CHU, A. (1990). Cytokine production in the rheumatoid joint: implications for treatment. Ann. Rheum. Dis., 49, 480-486.
25. FELDMANN, M., BRENNAN, F.M. & MAINI, R.N. (1996). Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol., 14, 397-440.
26. FERREIRA, S.H., LORENZETTI, B.B., BRISTOW, A.F. & POOLE, S. (1988). Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334, 698-700.
27. FERREIRA, S.H., LORENZETTI, B.B. & CORREA, F.M. (1978a). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol., 53, 39-49.
28. FERREIRA, S.H., LORENZETTI, B.B. & POOLE, S. (1993). Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol., 110, 1227-1231.
29. 2+ dependent process. Prostaglandins, 18, 179-190.
30. 2. Prostaglandins, 16, 31-37.
31. FRANCISCHI, J.N., YOKORO, C.M., POOLE, S., TAFURI, W.L., CUNHA, F.Q. & TEIXEIRA, M.M. (2000). Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur. J. Pharmacol., 399, 243-249.
32. FURST, D.E., SCHIFF, M.H., FLEISCHMANN, R.M., STRAND, V., BIRBARA, C.A., COMPAGNONE, D., FISCHKOFF, S.A. & CHARTASH, E.K. (2003). Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J. Rheumatol., 30, 2563-2571.
33. GADINA, M., BERTINI, R., MENGOZZI, M., ZANDALASINI, M., MANTOVANI, A. & GHEZZI, P. (1991). Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid- resistant models of endotoxic shock. J. Exp. Med., 173, 1305-1310.
34. GEORGE, A., MARZINIAK, M., SCHAFERS, M., TOYKA, K.V. & SOMMER, C. (2000). Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain, 88, 267-275.
35. GHEZZI, P., GARATTINI, S., MENNINI, T., BERTINI, R., DELGADO HERNANDEZ, R., BENIGNI, F., SACCO, S., SKORUPSKA, M., MENGOZZI, M., LATINI, R., KUROSAKI, M., LOMBET, A., FRADIN, A., BONNET, J., ROLLAND, Y. & BRION, J.D. (1996). Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice. Eur. J. Pharmacol., 317, 369-376.
36. GORDON, J.R., BURD, P.R. & GALLI, S.J. (1990). Mast cell as source of multifunctional cytokines. Immunol. Today, 11, 458-464.
37. GORIN, I., VILETTE, B., GEHANNO, P. & ESCANDE, J.P. (1990). Thalidomide in hyperalgic pharyngeal ulceration of AIDS. Lancet, 335, 1343.
38. GRANINGER, W., THALHAMMER, F. & LOCKER, G. (1991). Pentoxifylline in cerebral malaria. J. Infect. Dis., 164, 829.
39. HAYASHIDA, K., KANEKO, T., TAKEUCHI, T., SHIMIZU, H., ANDO, K. & HARADA, E. (2004). Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci., 66, 149-154.
40. HUIZINGA, T.W., DIJKMANS, B.A., VAN DER VELDE, E.A., VAN DE POUW KRAAN, T.C., VERWEIJ, C.L. & BREEDVELD, F.C. (1996). An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 55, 833-836.
41. JAKOUBEK, B. (1984). Analgesia induced by painful stimulation and/ or anticipation of pain; different mechanisms are operating. Physiol. Bohemoslov., 33, 171-178.
42. KOCH, A.E., KUNKEL, S.L. & STRIETER, R.M. (1995). Cytokines in rheumatoid arthritis. J. Invest. Med., 43 (1995), 28-38.
43. KOSTER, R., ANDERSON, M. & DE BEER, E.J. (1959). Acetic acid for analgesic screening. Fed. Proc., 18, 412.
44. LORENZETTI, B.B., VEIGA, F.H., CANETTI, C.A., POOLE, S., CUNHA, F.Q. & FERREIRA, S.H. (2002). Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivity in rats. Eur. Cytokine. Netw., 13, 456-461.
45. MARONE, G., COLUMBO, M., TRIGGIANI, M., CIRILLO, R., GENOVESE, A. & FORMISANO, S. (1987). Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem. Pharmacol., 36, 13-20.
46. MEHL-MADRONA, L.E. (1999). Comparison of ketorolac-chlorpromazine with meperidine-promethazine for treatment of exacerbations of chronic pain. J. Am. Board. Fam. Pract., 12, 188-194.
47. MERSKEY, H. (1997). Pharmacological approaches other than opioids in chronic non-cancer pain management. Acta Anaesthesiol. Scand., 41, 187-190.
48. MOREIRA, A.L., SAMPAIO, E.P., ZMUIDZINAS, A., FRINDT, P., SMITH, K.A. & KAPLAN, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med., 177, 1675-1680.
49. OHTSUKA, H., HIGUCHI, T., MATSUZAWA, H., SATO, H., TAKAHASHI, K., TAKAHASHI, J. & YOSHINO, T.O. (1997). Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. J. Vet. Med. Sci., 59, 1075-1077.
50. OLD, L.J. (1985). Tumor necrosis factor (TNF). Science, 230, 630.
51. OPPENHEIM, J.J. (2001). Cytokines: past, present and future. Int. J. Hematol., 74, 3-8.
52. PERKINS, M.N. & KELLY, D. (1994). Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology, 33, 657-660.
53. PEUCKMANN, V., STRUMPF, M., ZENZ, M. & BRUERA, E. (2003). [Novel potential uses of thalidomide in the management of pain? A review of the literature]. Schmerz., 17, 204-210.
54. PHILIP, R. & EPSTEIN, L.B. (1986). Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature, 323, 86-89.
55. POOLE, S., LORENZETTI, B.B., CUNHA, J.M., CUNHA, F.Q. & FERREIRA, S.H. (1999). Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol., 126, 649-656. Erratum in: Br. J. Pharmacol., 1999, 127, 314.
56. POOLE, S., LORENZETTI, B.B., CUNHA, J.M., CUNHA, F.Q. & FERREIRA, S.H. (1999). Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol., 126, 649-656. Erratum in: Br. J. Pharmacol., 1999, 127, 314.
57. PORTER, J.M., CUTLER, B.S., LEE, B.Y., REICH, T., REICHLE, F.A., SCOGIN, J.T. & STRANDNESS, D.E. (1982). Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am. Heart J., 104, 66-72.
58. 2 and cyclic nucleotides. J. Immunol., 141, 2388-2393.
59. RIBEIRO, R.A., VALE, M.L., THOMAZZI, S.M., PASCHOALATO, A.B., POOLE S FERREIRA, S.H. & CUNHA, F.Q. (2000a). Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur. J. Pharmacol., 387, 111-118.
60. RIBEIRO, R.A., VALE, M.L., FERREIRA, S.H. & CUNHA, F.Q. (2000b). Analgesic effect of thalidomide on inflammatory pain. Eur. J. Pharmacol., 391, 97-103.
61. ROCHA, F.A., ARAGAO JR, A.G., OLIVEIRA, R.C., POMPEU, M.M., VALE, M.R. & RIBEIRO, R.A. (1999). Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats. Inflamm. Res., 48, 485-490.
62. ROUVEIX, B. (1997). Clinical pharmacology of cytokines. Eur. Cytokine Netw., 8, 291-293.
63. SAFIEH-GARABEDIAN, B., POOLE, S., HADDAD, J.J., MASSAAD, C.A., JABBUR, S.J. & SAADE, N.E. (2002). The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology, 42, 864-872.
64. SAMPAIO, E.P., MORAES, M.O., NERY, J.A., SANTOS, A.R., MATOS, H.C. & SARNO, E.N. (1998). Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin. Exp. Immunol., 111, 300-308.
65. SAMPAIO, E.P., SARNO, E.N., GALILLY, R., COHN, Z.A. & KAPLAN, G. (1991). Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med., 173, 699-703.
66. SCHAFERS, M., GEIS, C., SVENSSON, C.I., LUO, Z.D. & SOMMER, C. (2003). Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur. J. Neurosci., 17, 791-804.
67. SCHANDNÉ, L., VANDENBUSSCHE, P., CRUSIAUX, A., ALEGRE, M.L., ABRAMOWICZ, D., DUPONT, E., CONTENT, J. & GOLDMAN, M. (1992). Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology, 76, 30-34.
68. SCHMIDT-CHOUDHURY, A., FURUTA, G.T., LAVIGNE, J.A., GALLI, S.J. & WERSHIL, B.K. (1996). The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol., 171, 140-146.
69. SCHWARZ, T., SCHWARZ, A., KRONE, C. & LUGER, T.A. (1993). Pentoxifylline suppresses allergic patch test reactions in humans. Arch. Dermatol., 129, 513-514.
70. SEMMLER, J., GEBERT, U., EISENHUT, T., MOELLER, J., SCHONHARTING, M.M., ALLERA, A. & ENDRES, S. (1993). Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology, 78, 520-525.
71. SHAFER, D.M., ASSAEL, L., WHITE, L.B. & ROSSOMANDO, E.F. (1994). Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J. Oral. Maxillofac. Surg., 52, 786-791; discussion 791-792.
72. SMITH, M.D., TRIANTAFILLOU, S., PARKER, A., YOUSSEF, P.P. & COLEMAN, M. (1997). Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J. Rheumatol., 24, 365-371.
73. SMITH, J.A., AMAGASU, S.M., EGLEN, R.M., HUNTER, J.C. & BLEY, K.R. (1998). Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol., 124, 513-523.
74. SOMMER, C., MARZINIAK, M. & MYERS, R.R. (1998). The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain, 74, 83-91.
75. THOMAZZI, S.M., RIBEIRO, R.A., CAMPOS, D.I., CUNHA, F.Q. & FERREIRA, S.H. (1997). Tumor necrosis factor, interleukin-1 and interleukin-8 mediates the nociceptive activity of the supernatant of LPS-stimulated macrophages. Mediat. Inflamm., 6, 195-200.
76. TONUSSI, C.R. & FERREIRA, S.H. (1992). Rat knee-joint carrageenin incapacitation test: an objective screen for central and peripheral analgesics. Pain, 48, 421-427.
77. TONUSSI, C.R. & FERREIRA, S.H. (1999). Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints. Pain, 82, 81-87.
78. VALE, M.L., MARQUES, J.B., MOREIRA, C.A., ROCHA, F.A., FERREIRA, S.H., POOLE, S., CUNHA, F.Q. & RIBEIRO, R.A. (2003). Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J. Pharmacol. Exp. Ther., 304, 102-108.
79. VAN FURTH, A.M., VERHARD-SEIJMONSBERGEN, E.M., VAN FURTH, R. & LANGERMANS, J.A. (1997). Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes. Immunology, 91, 193-196.
80. WARD, A. & CLISSOLD, S.P. (1987). Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs, 34, 50-97.
81. WEINBERG, J.B., MASON, S.N. & WORTHAM, T.S. (1992). Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation. Blood, 79, 3337-3343.
82. WOOLF, C.J., ALLCHORNE, A., SAFIEH-GARABEDIAN, B. & POOLE, S. (1997). Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol., 121, 417-424.
83. WORDLICZEK, J., SZCZEPANIK, A.M., BANACH, M., TURCHAN, J., ZEMBALA, M., SIEDLAR, M., PRZEWLOCKI, R., SEREDNICKI, W. & PRZEWLOCKA, D. (2000). The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci., 66, 1155-1164.
84. ZIMMERMANN, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.
85. ZINETTI, M., GALLI, G., DEMITRI, M.T., FANTUZZI, G., MINTO, M., GHEZZI, P., ALZANI, R., COZZI, E. & FRATELLI, M. (1995). Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro. Immunology, 86, 416-421.